Ark Therapeutics primes market for likely financing update

Viral product-focused manufacturing services company Ark Therapeutics expects to update the market soon regarding possible financing, an announcement issued by the company on Monday disclosed.

Viral product-focused manufacturing services company Ark Therapeutics expects to update the market soon regarding possible financing, an announcement issued by the company on Monday disclosed.

The group announced that it was actively pursuing a number of options regarding the possible financing of the company and its business, including through an issue of equity on a non pre-emptive basis.

The company stated that there was "no guarantee" that the discussions would be successful yet also stated that it believed it would be in a position to "update the market shortly".

This follows a previous attempt by the group to gauge interest among shareholders over a potential equity fund-raising which it said had showed a level insufficient to justify continuing with the proposal.

Over the past year, the company said it had reduced its cost base, terminated all costly investment in early stage product development and re-structured its business to focus solely upon generating revenue from its viral development and manufacturing services based in Finland.

The group advised its shareholders that "in all likelihood, given the current share price and the expected level of investment being discussed, any equity financing proposal will be materially dilutive and subject to shareholder approval."

It added that the group's directors remained confident Ark has the potential to become a profitable, viral focused, contract development and manufacturing organisation.

In the meantime, and as previously announced, the company continues to explore opportunities to monetise its non-core assets, and is in discussions with a number of interested parties.

Ark Therapeutics has seven active clients and a number of further contracts in late stage negotiations.

Unaudited revenue for 2012 was up 300% to approximately £1.8m compared to 2011.

MF

Recommended

Share tips of the week – 24 September
Share tips

Share tips of the week – 24 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
24 Sep 2021
Three strong Asian stocks trading at bargain prices
Share tips

Three strong Asian stocks trading at bargain prices

Professional investor Nitin Bajaj of the Fidelity Asian Values investment trust picks three stocks that dominate their industries, earn good returns o…
20 Sep 2021
Why it pays to face up to your investment mistakes
Investment strategy

Why it pays to face up to your investment mistakes

Buying stocks can be a complicated business. But selling stocks can be tricky, too – even if you sell for the right reasons. Max King explains how to …
17 Sep 2021
Share tips of the week – 17 September
Share tips

Share tips of the week – 17 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Sep 2021

Most Popular

Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
Should investors be worried about stagflation?
US Economy

Should investors be worried about stagflation?

The latest US employment data has raised the ugly spectre of “stagflation” – weak growth and high inflation. John Stepek looks at what’s going on and …
6 Sep 2021
The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021